|
|
Other links at Articles > Cardiology |
| 1. |
BART Closes the Book on Aprotinin
|
|
|
Results from the trial--halted last year due to safety concerns--clearly point to increased deaths in high-risk CABG patients randomized to aprotinin instead of a lysine-analog antifibrinolytic. Heartwire
|
|
|